← SynDRA
AZD-8330
SynDRA canonical compound SYN0037900 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | MAP3K1 |
| Mechanism of action | MEK inhibitor |
All known targets
Mechanisms of action (all sources)
- MAP2K1 INHIBITOR
- Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
- MAP2K2 INHIBITOR
- Dual specificity mitogen-activated protein kinase kinase 2 inhibitor
- MEK inhibitor
Cross-references
Synonyms
- Azd8330
- ARRY-424704
- ARRY-704
- AZD8330
- AZD 8330
- UNII-G4990BOZ66
- 2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide
- 2-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide
- G4990BOZ66
- C16H17FIN3O4
- 2-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxopyridine-3-carboxamide
- RWEVIPRMPFNTLO-UHFFFAOYSA-N
- ARRY 424704
- ARRY-424704, ARRY-704
- 2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxopyridine-3-carboxamide
- AZD8330(ARRY-424704; ARRY-704)
- 2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide.
- ARRY704
- MLS006011055
- SCHEMBL388533
- GTPL8474
- CHEMBL3182621
- CHEBI:91424
- DTXSID50235986
- AZD 8330 [WHO-DD]
- ARRY424704
- BCPP000359
- BDBM520648
- HMS3295M05
- HMS3655B04
- BCP02466
- EX-A2349
- NSC772563
- NSC799353
- s2134
- ZINC43152942
- AKOS027420927
- BCP9000368
Look up AZD-8330 in the interactive SynDRA portal →